209 related articles for article (PubMed ID: 17618030)
1. Distortion product otoacoustic emissions as non-invasive biomarkers and predictors of soman-induced central neurotoxicity: a preliminary study.
Job A; Baille V; Dorandeu F; Pouyatos B; Foquin A; Delacour C; Denis J; Carpentier P
Toxicology; 2007 Sep; 238(2-3):119-29. PubMed ID: 17618030
[TBL] [Abstract][Full Text] [Related]
2. Prediction of soman-induced cerebral damage by distortion product otoacoustic emissions.
Carpentier P; Pouyatos B; Dorandeu F; Campo P; Baille V; Foquin A; Job A
Toxicology; 2010 Nov; 277(1-3):38-48. PubMed ID: 20816720
[TBL] [Abstract][Full Text] [Related]
3. Effects of atropine sulphate on seizure activity and brain damage produced by soman in guinea-pigs: ECoG correlates of neuropathology.
Carpentier P; Foquin A; Rondouin G; Lerner-Natoli M; de Groot DM; Lallement G
Neurotoxicology; 2000 Aug; 21(4):521-40. PubMed ID: 11022861
[TBL] [Abstract][Full Text] [Related]
4. Magnetic resonance imaging reveals that galantamine prevents structural brain damage induced by an acute exposure of guinea pigs to soman.
Gullapalli RP; Aracava Y; Zhuo J; Helal Neto E; Wang J; Makris G; Merchenthaler I; Pereira EF; Albuquerque EX
Neurotoxicology; 2010 Jan; 31(1):67-76. PubMed ID: 19782102
[TBL] [Abstract][Full Text] [Related]
5. Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss.
Reavis KM; Phillips DS; Fausti SA; Gordon JS; Helt WJ; Wilmington D; Bratt GW; Konrad-Martin D
Ear Hear; 2008 Dec; 29(6):875-93. PubMed ID: 18753950
[TBL] [Abstract][Full Text] [Related]
6. Early changes in auditory function as a result of platinum chemotherapy: use of extended high-frequency audiometry and evoked distortion product otoacoustic emissions.
Knight KR; Kraemer DF; Winter C; Neuwelt EA
J Clin Oncol; 2007 Apr; 25(10):1190-5. PubMed ID: 17401008
[TBL] [Abstract][Full Text] [Related]
7. Soman-induced convulsions: the neuropathology revisited.
Baille V; Clarke PG; Brochier G; Dorandeu F; Verna JM; Four E; Lallement G; Carpentier P
Toxicology; 2005 Nov; 215(1-2):1-24. PubMed ID: 16054742
[TBL] [Abstract][Full Text] [Related]
8. Neurotoxicity of BFM-95 on the medial olivocochlear bundle assessed by means of contralateral suppression of 2f1-f2 distortion product otoacoustic emissions.
Riga M; Korres S; Psarommatis I; Varvutsi M; Giotakis I; Papadas T; Ferekidis E; Apostolopoulos N
Otol Neurotol; 2007 Feb; 28(2):208-12. PubMed ID: 17255889
[TBL] [Abstract][Full Text] [Related]
9. Protection by sustained release of physostigmine and procyclidine of soman poisoning in rats.
Choi EK; Park D; Yon JM; Hur GH; Ha YC; Che JH; Kim J; Shin S; Jang JY; Hwang SY; Seong YH; Kim DJ; Kim JC; Kim YB
Eur J Pharmacol; 2004 Nov; 505(1-3):83-91. PubMed ID: 15556140
[TBL] [Abstract][Full Text] [Related]
10. Protection against soman-induced neuropathology and respiratory failure: a comparison of the efficacy of diazepam and avizafone in guinea pig.
Taysse L; Daulon S; Delamanche S; Bellier B; Breton P
Toxicology; 2006 Aug; 225(1):25-35. PubMed ID: 16784801
[TBL] [Abstract][Full Text] [Related]
11. Changes in mouse brain metabolism following a convulsive dose of soman: a proton HRMAS NMR study.
Fauvelle F; Dorandeu F; Carpentier P; Foquin A; Rabeson H; Graveron-Demilly D; Arvers P; Testylier G
Toxicology; 2010 Jan; 267(1-3):99-111. PubMed ID: 19883723
[TBL] [Abstract][Full Text] [Related]
12. Gene expression profiling of rat hippocampus following exposure to the acetylcholinesterase inhibitor soman.
Dillman JF; Phillips CS; Kniffin DM; Tompkins CP; Hamilton TA; Kan RK
Chem Res Toxicol; 2009 Apr; 22(4):633-8. PubMed ID: 19281266
[TBL] [Abstract][Full Text] [Related]
13. Otoacoustic detection of risk of early hearing loss in ears with normal audiograms: a 3-year follow-up study.
Job A; Raynal M; Kossowski M; Studler M; Ghernaouti C; Baffioni-Venturi A; Roux A; Darolles C; Guelorget A
Hear Res; 2009 May; 251(1-2):10-6. PubMed ID: 19249340
[TBL] [Abstract][Full Text] [Related]
14. [Hearing evaluation in children during chemotherapy].
Lisowska G; Namysłowski G; Hajduk A; Polok A; Tomaszewska R; Misiołek M
Pol Merkur Lekarski; 2005 Sep; 19(111):340-2. PubMed ID: 16358863
[TBL] [Abstract][Full Text] [Related]
15. Distortion-product otoacoustic emission: early detection in deferoxamine induced ototoxicity.
Delehaye E; Capobianco S; Bertetto IB; Meloni F
Auris Nasus Larynx; 2008 Jun; 35(2):198-202. PubMed ID: 17869044
[TBL] [Abstract][Full Text] [Related]
16. Disruption of mice sleep stages induced by low doses of organophosphorus compound soman.
Crouzier D; Le Crom VB; Four E; Lallement G; Testylier G
Toxicology; 2004 Jun; 199(1):59-71. PubMed ID: 15125999
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of the anticonvulsant and neuroprotective efficacy of propentofylline during soman poisoning].
Lallement G; Pernot-Marino I; Masqueliez C; Baubichon D; Blanchet G
C R Acad Sci III; 1993 Oct; 316(10):1250-4. PubMed ID: 8062133
[TBL] [Abstract][Full Text] [Related]
18. Hearing loss in vestibular schwannomas: analysis of cochlear function by means of distortion-product otoacoustic emissions.
Ferri GG; Modugno GC; Calbucci F; Ceroni AR; Pirodda A
Auris Nasus Larynx; 2009 Dec; 36(6):644-8. PubMed ID: 19419826
[TBL] [Abstract][Full Text] [Related]
19. Analyzing large data sets acquired through telemetry from rats exposed to organophosphorous compounds: an EEG study.
de Araujo Furtado M; Zheng A; Sedigh-Sarvestani M; Lumley L; Lichtenstein S; Yourick D
J Neurosci Methods; 2009 Oct; 184(1):176-83. PubMed ID: 19632275
[TBL] [Abstract][Full Text] [Related]
20. Distortion product otoacoustic emissions in an industrial setting.
Korres GS; Balatsouras DG; Tzagaroulakis A; Kandiloros D; Ferekidou E; Korres S
Noise Health; 2009; 11(43):103-10. PubMed ID: 19414930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
